Gradual increase of avacopan dose with concomitant ursodeoxycholic acid use may help avoid the risk of C5a receptor inhibitor-induced liver injury in antineutrophil cytoplasmic antibody-associated vasculitis.

Autor:	Kataoka, Hiroshi1 (AUTHOR) hiroshi.kataoka@doc.city.sapporo.jp, Tomita, Tomoko1 (AUTHOR), Nakanowatari, Mika1 (AUTHOR), Kondo, Makoto1 (AUTHOR), Mukai, Masaya1 (AUTHOR)
Zdroj:	Modern Rheumatology Case Reports. Jul2023, Vol. 7 Issue 2, p444-447. 4p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu